Pearls and pitfalls of oral carbapenem/penem agents: the promise of a new era or the risk of amplified resistance?
{{output}}
Introduction: The rising prevalence of MDR Gram-negative infections, particularly ESBL-producing Enterobacterales, has created a critical oral treatment gap, necessitating prolonged intravenous therapy. Oral carbapenems/penems of... ...
